Morgan Stanley Rigel Pharmaceuticals Inc Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Oct 17, 2024
BUY
$1.12 - $1.57 $16.2 Million - $22.7 Million
14,440,858 New
14,440,858 $21.4 Million
Q1 2024

Aug 16, 2024
SELL
$1.12 - $1.57 $15,966 - $22,381
-14,256 Reduced 0.1%
14,440,858 $21.4 Million
Q1 2024

May 15, 2024
SELL
$1.12 - $1.57 $15,966 - $22,381
-14,256 Reduced 0.1%
14,440,858 $21.4 Million
Q4 2023

Aug 16, 2024
BUY
$0.72 - $1.56 $10.4 Million - $22.5 Million
14,455,114 New
14,455,114 $21 Million
Q4 2023

Feb 13, 2024
BUY
$0.72 - $1.56 $5.38 Million - $11.7 Million
7,472,639 Added 107.02%
14,455,114 $21 Million
Q3 2023

Nov 15, 2023
BUY
$1.07 - $1.39 $3.34 Million - $4.33 Million
3,118,154 Added 80.69%
6,982,475 $7.54 Million
Q2 2023

Aug 14, 2023
BUY
$1.12 - $1.82 $3.77 Million - $6.12 Million
3,364,508 Added 673.15%
3,864,321 $4.98 Million
Q1 2023

May 15, 2023
SELL
$1.25 - $2.0 $131,390 - $210,224
-105,112 Reduced 17.38%
499,813 $659,000
Q4 2022

Feb 14, 2023
SELL
$0.67 - $11.9 $199,422 - $3.54 Million
-297,645 Reduced 32.98%
604,925 $907,000
Q3 2022

Nov 14, 2022
SELL
$1.1 - $12.2 $1.42 Million - $15.7 Million
-1,286,408 Reduced 58.77%
902,570 $1.06 Million
Q2 2022

Oct 27, 2022
BUY
$0.67 - $3.19 $705,160 - $3.36 Million
1,052,478 Added 92.61%
2,188,978 $2.47 Million
Q2 2022

Aug 15, 2022
BUY
$0.67 - $3.19 $705,160 - $3.36 Million
1,052,478 Added 92.61%
2,188,978 $2.47 Million
Q1 2022

Oct 27, 2022
SELL
$2.22 - $3.45 $2.34 Million - $3.63 Million
-1,052,478 Reduced 48.08%
1,136,500 $3.4 Million
Q1 2022

May 13, 2022
BUY
$2.22 - $3.45 $596,272 - $926,638
268,591 Added 30.95%
1,136,500 $3.4 Million
Q4 2021

Feb 14, 2022
SELL
$2.36 - $3.57 $460,499 - $696,603
-195,127 Reduced 18.36%
867,909 $2.3 Million
Q3 2021

Nov 15, 2021
BUY
$3.5 - $4.5 $3.72 Million - $4.78 Million
1,063,036 New
1,063,036 $3.86 Million

Others Institutions Holding RIGL

# of Institutions
8
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.95B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email